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 It has been shown that stem cells exist within adult adipose tissue. These stem cells are 
named adipose-derived mesenchymal stem cells (ASCs), are derived from the mesoderm, and 
can differentiate into a number of cells including osteoblasts, chondrocytes, and adipocytes.  
However, before these cells can be used clinically it is important that we understand how factors 
like age, sex, and ethnicity affect ASC number and potential. Additionally, since men and 
women vary in their distribution of adipose tissue, it will be important to see if the ideal source 
of ASCs is different for each sex. The goal of this study was to assess how age and sex affects 
ASCs. We used flow cytometry to investigate how age and sex affected the number of ASCs in 
adipose tissue. Additionally, we plated these cells in culture and treated them with an osteogenic 
media (OM) with the intention of pushing them towards osteoblast differentiation. The purpose 
of this was to see if age or sex affected the potential of the ASCs to undergo osteogenesis in 
culture. For this study we used real-time PCR and biochemical assays to look at markers of early 
and late osteogenic differentiation. Finally, we used immunohistochemistry to demonstrate 
where in adipose tissue the CD73 and CD271 positive cell population exists. It is our hope that 
this work will shed light on how age and sex affect ASCs so that clinicians can optimize their 
ASC harvest depending on the patient’s physiology.  
 Methods: Adipose tissue was harvested from the inguinal fat pad of 1M, 3M, and 9M 
male rats, and 3M and 9M female rats. The tissue was washed several times and then digested 
with trypsin, collagenase, and dispase. After the isolation procedure we were left with the 
stromal vascular fraction containing ASCs as well as other cell sources like fibroblasts, red blood 
cells, and endothelial cells. Using flow cytometry we assessed the primary cells for the number 
and percentage of ASCs and osteoprogenitor cells (OPCs). We used a combination of antibodies 
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to denote a cell as either an ASC or OPC. ASCs were CD73 and CD271 positive, and CD45 
negative. OPCs were osteocalcin (OCN) and E11 positive. We also paraffin embedded adipose 
tissue and stained 5um slices with CD73/CD271, von Willebrand Factor, hematoxylin and eosin, 
or a control antibody to see where our ASC population exists. Additionally, we plated ASCs on 
tissue-cultured polystyrene and grew them in a mesenchymal growth media (GM) or OM for 7 
and 14 days. At these time points we harvested the cells and looked at markers of osteogenesis. 
We ran biochemical assays looking for the activity and levels of alkaline phosphatase (ALPase), 
OCN, and osteoprotegerin (OPG). We also ran real-time PCR to look for the expression of 
RUNX2, ALPase, OCN, and Bone Sialoprotein (BSP).  
 Results: From the initial flow cytometry we discovered that the number and percentage of 
ASCs decreases as the animal gets older. On the other hand, sex did not have an effect on the 
number of ASCs. We also discovered that the percentage of OPCs increases as the animal gets 
older. When we compared the sexes, there was no difference at 3M, but at 9M the females had 
more OPCs. We also noticed that the young and old animals had different tissue morphologies. 
The younger animals had white adipose tissue while the older animals had brown adipose tissue. 
The histology showed that the CD73+/CD271+ cells are localized to the vasculature and we saw 
co-localization of the antibodies in the capillaries and veins. When the cells were cultured in OM 
they all expressed markers of osteogenesis indicating that they had a similar potential for 
osteogenesis. However, differences were seen between the ages and sexes. The younger cells 
proliferated at a greater rate than the older cells in the GM. Additionally, the older cells secreted 
and expressed more OCN. The major difference between the sexes is that the males decreased 
their secretion of OPG in the OM while the female cells maintained similar levels in both 
medias.  
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  Discussion: The results indicate that in older age the adipose-derived number of ASCs 
decreases and the number of OPCs increases. Although our technique to examine ASC and OPC 
number is unique, the results agree with other studies showing that the number of adult stem 
cells decreases with age. This is important because it indicates that retrieving ASCs from older 
patients may require more tissue and/or pretreatment to increase the number of stem cells. 
Furthermore, the results indicate that the osteogenic potential of ASCs does not decrease with 
age. This is interesting because the ability to regenerate damaged tissue does decrease with age. 
This would imply that the decrease in tissue regeneration could be attributed to a lowered stem 
cell number, or as other researchers have discovered, the cues required to trigger stem cell 
migration are altered with age.  
 The results of the sex study indicate the neither ASC number nor osteogenic potential 
changes between the sexes. These results disagree with other studies showing that male ASCs 
have a higher osteogenic potential than female ASCs. The difference between our studies is the 
animal model and tissue source. This is important because the ideal site to harvest ASCs may be 





Adipose Tissue as a Source of Mesenchymal Stem Cells 
 It was demonstrated in 2001 that multipotent stem cells exist within adipose tissue (Zuk 
et al., 2001).  Since then research has shown that these stem cells are similar in the 
immunophenotype and differentiation potential as the mesenchymal stem cells found within the 
bone marrow (Kern et al., 2006; Liu et al., 2009).  Therefore these adipose-derived 
mesenchymal stem cells (ASC) are an attractive source for regenerative medicine because they 
can differentiate into many tissue lineages including osteoblasts, chondrocytes, and adipocytes. 
Using adipose tissue as a source of stem cells is advantageous over other sources for several 
reasons.  As a source of adult stem cells, working with adipose tissue avoids the ethical dilemma 
associated with embryonic stem cells. Additionally, adipose tissue is easier to isolate than most 
stem cell sources (especially compared with bone marrow), it is abundant in humans, and the 
stem cells proliferate rapidly in culture. Furthermore, several studies have shown that ASCs do 
not express the major immunologic surface antigens and therefore do not elicit an allogenic 
immune response (Niemeyer et al., 2007). Due to these findings this young field of ASCs has 
blossomed over the past decade as researchers continue to study the differentiation potential and 
regenerative capacity of these cells. 
 While much attention has been given to ASCs over the past decade, many questions need 
to be addressed before these cells can be used clinically.  Some of the main questions deal with 
how age, sex, ethnicity, and anatomical source affect the number and differentiation potential of 
ASCs. It has already been shown that changes in some of these variables will affect the potential 
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of ASCs to differentiate. One study compared visceral and subcutaneous ASCs from rabbits and 
discovered that while subcutaneous ASCs proliferated more, ASCs from visceral adipose tissue 
had a higher osteogenic potential (Peptan et al., 2006). This was attributed to the cellular makeup 
and vasculature of the adipose tissue.  Since the cells isolated from adipose tissue have a 
heterogeneous phenotype, the cells from one adipose depot may differ from the cells in another 
depot.  The two variables that this paper focuses on are how the age and sex of the donor affects 
the number of adipose-derived mesenchymal stem cells and their osteogenic differentiation 
potential. These questions are important to answer because the results will enable researchers to 
optimize their patient’s ASC treatment depending on the donor’s source of adipose tissue, age, 
sex, etc.  It is possible that each patient may require a treatment that is tailored to his/her 
physiology and needs.  
Role of Aging in Stem Cells 
 Our regenerative capacity has been shown to decrease as we age, especially our ability to 
repair injuries to our musculoskeletal system (D’lppolito et al., 1999; Fisher et al., 2009).  A few 
possible explanations are that as we age we lose the number of stem cells in our reservoir, the 
ability of these to cells to undergo differentiation decreases with age, and that the extrinsic 
factors required to stimulate stem cell migration and differentiation are altered with age. Some 
studies have shown a decrease in gene expression with age, leading to a decline in stem cell 
migration, adhesion, and protection from DNA damage (Wagner et al., 2009; Kasper et al., 
2009).  Several studies have investigated the effect of aging on ASCs osteogenesis, but the 
results have been conflicting. This is partially due to the lack of uniformity in ASC studies. 
While human adipose tissue is the ideal source for studying ASCs, it is difficult to acquire this 
tissue from multiple patients with a similar age, gender, and anatomical source of extracted 
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adipose tissue. Furthermore, animal studies differ in their isolation method, culture medium, and 
biochemical assays used to quantify number of stem cells or level of differentiation.  A study by 
Shi et al. (2004) observed that osteogenic potential was maintained with aging, while another 
study by Kasper et al. (2009) reports that the osteogenic potential of ASCs can decrease with 
age. Whatever the differences may be attributed to, it is likely that a difference in aged ASCs, 
whether intrinsic or extrinsic, does exist, and it will be important to elucidate the age related 
changes so that we can optimize future stem cell therapies. The advantage of the study being 
presented here is that the researcher has investigated both stem cell number and osteogenic 
potential. By addressing both the number of ASCs and osteoprogenitor cells (OPCs) present in 
primary tissue, as well as the osteogenic potential in culture, a more complete picture can be 
created on the potential of stem cells from adipose tissue. Additionally, while most studies have 
focused on histological assays for osteogenesis, this study includes gene studies and biochemical 
assays. The advantage of this method is that it will not only address differences in osteogenic 
potential between ASC sources, but also help researchers understand the causes of these 
differences.  
Role of Sex in Stem Cells 
 Another factor that this paper investigates is how the sex of the individual affects their 
ASC potential.  It is important to investigate the role of sex on ASCs because the amount and 
distribution of adipose tissue between men and women is not the same (Freedman et al, 1990).  
This is due to a hormonal difference between men and women that develops as they reach 
puberty leading to contrasting levels of testosterone and estrogen (Guyton and Hall, 2000). For 
this reason, it may turn out that the optimal site to harvest ASCs is different between men and 
women.  Additionally, the hormonal balance between men and women changes throughout their 
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lives, and therefore the microenvironment of the ASC will alter as the individual ages.  For 
example, women experience a drop in estrogen levels as they reach menopause (Luftkin et al, 
1992). This decline in estrogen leads to a reduction in osteoblastic activity and an increased 
susceptibility to bone disorders like osteoporosis (Riggs et al., 1998).  Since estrogen can be 
metabolized in adipose tissue by conversion of androgen via aromatase, it may turn out that a 
difference in the level of adipose-derived estrogen, as well as the response to this steroid, can 
affect the ability of ASCs to differentiate into osteoblasts (Simpson et al., 1981).  Therefore, the 
difference in hormone levels between men and women may affect their ASC differentiation 
potential, and this potential may continue to change as men and women age and their hormonal 
balance alters.  Additionally, any differences in the ASC phenotype between men and women 
may cause the cells to react differently in vitro.  By addressing both the initial ASC and OPC 
populations, as well as the osteogenic potential of ASCs in culture, it is the hope of the 
researcher to shed some light on the differences, if any, between the two sexes.  
The Use of Flow Cytometry in Addressing the Primary ASC and OPC Populations 
 The initial goal of the researcher was to quantify the number of ASCs and OPCs isolated 
from the stromal vascular fraction of adipose tissue per gram of fat.  To achieve this, the 
researcher used flow cytometry and denoted a positive population based on the cell’s 
immunophenotype.  Unlike embryonic stem cells, no specific markers for ASCs exists, so 
therefore a combination of markers were used to pinpoint a specific cell type.  The ASCs were 
declared as being CD271 positive, CD73 positive, and CD45 negative.  CD45, the common 
leukocyte antigen, was used to eliminate the population of cells from the hematopoietic lineage, 
which in some cases included up to 20% of the isolated cells.  CD45 has been found on the 
surface of cells from the haematopoietic lineage, but not on the surface of ASCs (Schaffler et al., 
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2007). We used CD271 and CD73 as positive markers of ASCs because previous research has 
shown that adipose-derived cells positive for these markers can be pushed towards osteogenesis 
when given the right media (Mitchell et al., 2006; Astori et al., 2007; Quirici et al., 2002; Barry 
et al., 2001). CD271, low-affinity nerve growth factor receptor, was originally identified in a 
population of bone marrow cells that stained positive for alizarin red in vitro (Quirici et. al, 
2002). Since then this protein has been found on the surface of adipose-derived cells that 
undergo osteogenesis in culture (Quirici et. al, 2009). Although the exact role of this marker in 
ASCs is not known, it is thought to present growth factors involved in morphogenesis.  CD73, 
ecto-5’ nucleotidase, was also originally described as being present on the surface of bone 
marrow cells (Barry et. al, 2001). This phosphatidylinositol-anchored protein is thought to be 
involved in signal transduction and dephosphorylation of purines and pyrimidines into 
nucleosides. Current research has shown that adipose-derived cells positive for this marker 
demonstrate an osteoblast phenotype when treated with induction media in culture. (Leong et al., 
2006). Based upon these studies and others, we believed that using our three markers in 
conjunction with one another allowed our group to compare the number and percent of ASCs 
across different ages and sexes.   
 The other cell type that was investigated in primary tissue and in culture was an OPC.  
The OPC is a MSC that has started to differentiate towards the osteoblast lineage, usually seen 
by an increase in RUNX2 and alkaline phosphatase protein levels. The two surface markers used 
to identify this cell type were E11 and osteocalcin (OCN). E11, podoplanin, is a hydrophobic 
glycoprotein that is necessary for the elongation of the dendritic processes in osteocytes (Zhang 
et al., 2006).  It has been noted that ASCs will increase their dendritic processes needed for 
cellular communication towards the end of osteogenic differentiation, and this increase has been 
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correlated with an increase in E11 expression (Elabd et al., 2007).  We used E11 as a marker to 
identify the cells in primary tissue that have started to differentiate into an osteocytes, and the 
cells in culture that have formed the phenotype associated with osteocytes.  The other marker we 
used, OCN, is a well-known marker associated with end stage osteogenesis. This small protein is 
secreted by osteoblasts and plays a role in mineralization and calcium-ion homeostasis by 
binding calcium in the extracellular matrix.  Even though cells secrete OCN, it was shown that 
this protein could be identified on the cell’s surface using flow cytometry (Eghbali-Fatourechi et 
al., 2007).  The reason is that either OCN uses its Gla residues to temporarily bind the cell 
surface as it’s secreted, or that OCN binds to an OCN receptor. This evidence has indicated that 
OCN is another marker that can be used in extracellular flow cytometry to define a population of 
cells displaying an osteoblast phenotype and having undergone later differentiation. It is believed 
that a cell positive for E11 and OCN has left the multipotent stem cell state and has started to 
undergo osteogenesis, or is already a mature bone cell.   
 The researcher used flow cytometry to determine both the percentage of cells positive for 
the markers listed above and also to figure out the number of cells per gram of adipose tissue 
positive for these markers.  The purpose of this second goal was to gather a more clinically 
relevant number.  For example, even if the percentage of ASCs is higher in one population, if the 
total tissue or cellular yield is lower, then the total number of ASCs might also be lower. Given 
this information, a clinician can more easily determine the amount of adipose tissue necessary in 
order to achieve a desired number of ASCs.  Therefore, the researcher correlated the percent of 
ASC and OPC positive cells, with the number of cells per gram of adipose tissue, to extract the 




Correlating Rat and Human Ages: Rationale Behind the Ages We Chose 
 To study age we used only male rats that were 4 weeks, 12 weeks, and 36 weeks old upon 
arrival. We focused on these ages because they correlate with humans that are in different stages 
of maturation (Fisher et al., 2009).  At 4-weeks the rats have not yet reached sexual maturity and 
so they can be compared to a human who is somewhere between childhood and early 
adolescence (Quinn et al., 2005).  At 12-weeks the rats have reached sexual maturity and they 
are also continuing to grow, so these animals can be considered adults. Finally, at 36-weeks the 
rats have stopped growing but unlike humans there is no epiphyseal closure in the long bones 
(Harlan Growth Chart1). Due to these circumstances our group considers the 36-week rats as an 
aged population. 
  In addition to looking at the effect of age on ASCs, we also investigated the role 
sex plays. We chose to focus our study on 3M and 9M male and female rats.  We chose these 
ages because at 3M the rats are just starting their sexual maturity, and at 9M they have stopped 
their skeletal development. Due to these circumstances, we believe that the adipose 







SPECIFIC AIMS AND EXPERIMENTAL DESIGN 
  The overall goals of this thesis are to investigate the effects age and sex have on the 
number of adipose-derived stem cells in the inguinal fat pad, and to study the effects age and sex 
have on the osteogenic differentiation potential of these ASCs.  The general hypothesis is that 
age, but not sex, will affect the number of ASCs in the inguinal fat pad. Furthermore, we believe 
that both age and sex will affect how these cells respond to our osteogenic media, and therefore 
the osteogenic differentiation potential of these cells.  
 
Aim 1: To study the effect age has on ASCs; this was divided into three sub-aims.  
Aim 1.1: To investigate how age affects the number of ASCs in the inguinal fat pad. The 
objective of this aim was to study the number of ASCs and OPCs in the inguinal fat pad of 1M, 
3M, and 9M male Sprague-Dawley rats. We achieved this by staining our cells with antibodies 
of extracellular markers of ASCs and OPCs. By using a combination of antibodies we were able 
to extract the ASC and OPC percent and number using flow cytometry. Our hypothesis was that 
the older animals would have a lower percent and number of ASCs. We believed this to be the 
case since older animals have a decreased ability to regenerate their tissue, and a reduction in the 
number of stem cells could be a reason why.  
Aim 1.2: To discover the location of CD73 and CD271 positive ASCs. The objective of this aim 
was to use histological methods on adipose tissue to find cells positive for both of our ASC 
markers. We paraffin embedded adipose tissue from 6-week males and stained the tissue slices 
with antibodies for CD73/CD271 or vWF. We then stained them with a secondary fluorescent 
antibody and visualized the histology on a light microscope with a camera attached. Our 
hypothesis is that the ASCs would be found in or around the vasculature. We believed this to be 
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the case because the vasculature is a large component of the stromal vasculature fraction that we 
isolate from the adipose tissue.  
Aim 1.3: To investigate how age affects the osteogenic differentiation potential of ASCs from 
the inguinal fat pad. The objective of this aim was to study the osteogenic differentiation 
potential of ASCs in culture on TCPS. We plated 1M, 3M, and 9M male Sprague-Dawley rat 
ASCs on TCPS and fed them with GM and OM for 7 and 14 days. At these time points we used 
flow cytometry, Real-Time PCR, and biochemical assays to study their expression and level of 
some common markers of osteogenesis.  Our hypothesis was that the older animals would have 
a decreased potential for osteogenesis. This was our rationale because older animals have a 
decreased ability to repair damaged tissue, and also some studies have shown that MSCs from 
older animals have a decreased ability to undergo osteogenesis.  
 
Aim 2: To study the effect sex has on ASCs; this was divided into two sub-aims. 
Aim 2.1: To study the role sex has on the number of ASCs in the inguinal fat pad. The objective 
of this aim was to study the number of ASCs and OPCs in the inguinal fat pad of 3M and 9M 
male and female Sprague-Dawley rats. We achieved this by staining our cells for markers of 
ASCs and OPCs and then using flow cytometry to figure out the number and percent of these 
cells. Our hypothesis was that sex would not affect the number of ASC and OPCs. We believed 
this to be the case since the animals are of a similar age and should have equal abilities to 
regenerate tissue. Therefore, sex should not be a factor in this process.  
Aim 2.2: To investigate how sex affects the osteogenic differentiation potential of ASCs from 
the inguinal fat pad. The objective of this aim was to study the osteogenic differentiation 
potential of 3M and 9M male and female rat ASCs in culture on TCPS. We plated these cells on 
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TCPS and fed them with either a GM or an OM for 7 and 14 days. At these time points we used 
flow cytometry, Real-Time PCR, and biochemical assays to study their ability to undergo 
osteogenesis. Our hypothesis was that the female ASCs would have a decreased ability to 
differentiate. Our rationale behind this is that older females experience more bone turnover, an 
increase in osteoclastogenesis, and suffer more from conditions like osteoporosis. We believe 
that differences in the female ASC caused by exposure to their unique environmental niche may 
cause a reduction in the potential of their ASCs to undergo osteogenesis. 
 
METHODS 
Tissue Dissection  
 Sprague Dawley rats were purchased from Harlan Laboratories for this study. We 
examined male rats that were 4 weeks, 12 weeks, and 36 weeks old upon arrival for the first aim.  
For the second aim we used male and female rats that were 12 weeks and 36 weeks old upon 
arrival. For each study the animals were dissected and the cells harvested concurrently to 
maximize the number of comparisons possible. The Institutional Animal Care and Use 
Committee (IACUC) of the Georgia Institute of Technology approved the study.  The rats were 
euthanized with CO2 and then placed on an operating board. The legs were washed with ethanol 
and betadine two times, and sterile surgical gauze was used to remove any remaining solution. 
Using autoclaved scissors the initial incision was made from the ankle to the torso, exposing the 
inguinal fat pad of both legs. After the incision adipose tissue was removed and then 
immediately placed in a 50mL conical tubes with 10mL of Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 3% sterile-filtered L-Glutamine-penicillin-streptomycin (P/S).  The 




After the dissection, the adipose tissue was then brought under a sterile laminar flow 
hood and washed three times with 10mL of DMEM + 3% P/S and two times with 15mL of 
phosphate buffered saline (PBS) with 1% P/S. After the second wash the PBS was removed, and 
the tissue was incubated on a rocking platform shaker at 37oC in 5mL of trypsin for 30 minutes.  
After the incubation the trypsin was quenched with 10mL of DMEM with 10% fetal bovine 
serum (FBS) and 1%P/S. The tissue was then secured with a hemostat and cut directly into a new 
50mL conical tube with scissors. The adipose tissue was then treated with 15mL of our digestion 
cocktail which included sterile filtered DMEM + 1% P/S supplemented with collagenase type I 
(365units/mL) and dispase (3units/mL). The conical tube was then incubated on a rocking 
platform shaker at 37oC for three hours. After the digestion the cell suspension was transferred 
through a 40µm cell strainer into a new conical tube, and the reaction was quenched with 15mL 
DMEM + 10% FBS + 1% P/S (Full Media).  The cells were then spun down three times in a 
centrifuge at 2000 RPM for 10 minutes. Following each spin, the supernatant was aspirated and 
the cells were washed with PBS + 1% P/S. After the last wash the number of cells was counted 
on a Beckman Coulter Z-1 particle counter.  Two hundred thousand cells from each group were 
plated in a V-bottom 96-well plate for flow cytometry. The remaining cells were grouped 
together by age, spun down at 2000 RPM for 5 minutes, and then recounted. The cells were 
plated on a tissue-cultured polystyrene (TCPS) T-75 at 5,000 cells/cm2 and fed with 10mL of 
Mesenchymal Stem Cell Growth Media (Lonza, GM, PT-3001). Each group had 5 T-75s with 
375,000 cells/flask.   
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Histology 
Adipose tissue from the inguinal fat pad of 6-week old male Sprague-Dawley rats was 
fixed with 10% neutral buffered formalin and then paraffin embedded.  5µm tissue slices were 
prepared. The tissue was deparaffinized and select samples were processed for Hematoxylin and 
Eosin staining. Antigen retrieval was performed on the remaining sections using a pressure 
cooker with the samples incubated in sodium citrate buffer pH 4.2. The samples were blocked 
with 10% normal goat serum in PBS for 60 minutes. Immunostaining was performed using a 
monoclonal CD271 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, SC-71691) 
conjugated to Alexa Fluor 488 (Invitrogen, A11001), a polyclonal CD73 antibody (Santa Cruz 
Biotechnology, SC-25603) conjugated to Alexa Fluor 594 (Invitrogen, A11012), and a 
polyclonal Von Willebrand Antibody (vWF, Abcam, Cambridge, MA, AB6994) conjugated to 
Alexa Fluor 594. The primary antibodies were incubated on the samples overnight at 4oC while 
the secondary antibodies were on the samples for 60 minutes. vWF was used as a positive 
marker for the vasculature because it is expressed in endothelial cells [47]. One section was 
stained for both CD271 and CD73 and another section was stained for vWF. The negative 
controls used were a rabbit IgG (Thermo Fisher Scientific, NC-100-P) conjugated to Alexa Fluor 
594 and a mouse IgG (Santa Cruz Biotechnology, SC-2025) conjugated to Alexa Fluor 488. 
Images were taken on an ORCA-ER digital camera (Hamamatsu Photonics K.K., Hamamatsu 
City, Japan, C4742-80-12AG) attached to a Leica DMLB microscope (Leica, Wetzlar, Germany, 
DFC420), and the images were processed using SimplePCI 6 software (Compix Inc. Imaging 




The cells were kept in a T-75 until 90% confluence, fed with GM every two days, and 
then passaged into 6-well plates. Each group of 5 T-75s was divided among 20 plates at a 
seeding dentistry of 5,000 cells/cm2. A day after passage the wells were washed with PBS to 
remove the non-adherent cells, and the remaining cells were fed with either GM or a 
Mesenchymal Stem Cell Osteogenic Differentiation Medium (Lonza, OM, PT-3002). This was 
counted as day 1 of cell induction. The 20 6-well plates were broken into four groups of 5 and 
treated with either 2mL of GM or OM every two days and harvested at 7 or 14 days. 24 hours 
before harvest the media was changed, and 12 hours after that the RNA was collected as 
described below. At each harvest time point the remaining cells were used as described below for 
the biochemical assays. 
 



















Flow cytometry was run on the primary cells after isolation, and on the cells immediately 
following the 7 day and 14 day harvests. After the cell number was counted, 200,000 cells were 
aliquot to a V-bottom 96-well plate (BD Bioscience 353263). The cells were stained for cell 
surface markers of mesenchymal stem cells, osteoprogenitor cells, or as a negative control. The 
mesenchymal stem cells were denoted as CD73+, CD271+, and CD45-. The osteoprogenitor 
cells were determined to be E11+ and OCN+. The negative controls were either secondary 
antibodies alone, or control isotype antibodies. A comprehensive list of the antibodies and 
staining steps is listed below. For the primary cells, the six rat cells were kept isolated throughout 
the tissue digestion. After the cells were counted, the 200,000 were added to two groups, 
mesenchymal stem cells and osteoprogenitor cells, for an n of 6. The remaining cells were 
combined and then 200,000 cells were added to another 6 wells as the controls.  For the cells in 
culture, 3 plates were cultured for each group, one for MSCs, one for OPCs, and one for the 
controls. The cells were washed 3 times in 200µL of 1% PBS with BSA and stained for 30 
minutes at room temperature on a VWR rocking platform.  Between washings the cells were 
spun down at 2000 RPM for 5 minutes, and the supernatant was aspirated. After the last stain the 
cells were washed three times with 200µL of 1X PBS and added through a 40µm cell strainer to 
a TCPS Round Bottom Test Tube (VWR 60819-310). The samples were run through a BD LSR 
Flow Cytometer, and the data was recorded with the BD Bioscience FACSCalibur software. The 
cells were recorded as positive if they exceeded the negative control 5% threshold.  For the 
primary cells the percent positive was normalized to cell number and fat weight to get the total 
number of positive cells per gram of adipose tissue.  
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Table 2 – Flow Cytometry Antibodies 
Flow Cytometry Antibodies and Controls 
Mesenchymal Stem Cell Markers  
Antibody Company Moniker 
Addition 
Step 
Mouse Anti-Rat Ecto-5'-Nucleotidase BD Pharmigen 551123 CD73 1 
FITC Mouse Anti-Rat Leukocyte Common Antigen BD Pharmigen 554877 CD45 3 
PE Goat Anti-Rat NGFR P75 (C-20) Santa Cruz SC-6188PE CD271 3 
Osteoprotegitor Cell Marker 
Antibody Company Moniker 
Addition 
Step 
Rabbit Anti-Rat Podoplanin (KS-17) Sigma P2120 E11 1 
Goat Anti-Rat Osteocalcin (V-19) Santa Cruz sc-18319 OCN 1 
Secondary and Negative Control 
Antibody Company Type 
Addition 
Step 
APC Goat F(ab')2 Anti-Mouse IgG R&D F0101B CD73 Secondary/Control 2 
Mouse IgG1-FITC Isotype Control BD Bioscience 550616 CD45 Isotype Control 3 
Goat IgG1-PE Isotype Control Santa Cruz SC-3993 CD271 Isotype Control 3 
FITC Chicken Polyclonal to Rabbit IgG  Abcam ab6825 E11 Secondary/Control 2 
APC Donkey Anti-Goat IgG R&D F0108 OCN Secondary/Control 2 






RNA Extraction and Real-Time PCR 
Twelve hours after the last media change one plate from both the GM and OM groups 
were used for real-time PCR. After the media was aspirated the cells were extracted using Trizol 
Reagent (Invitrogen 15596-018) and stored in 15mL conical tubes kept in the -80oC freezer. The 
lysed cells were kept in the -80oC until the final harvest so that the cells from all 24 wells could 
be reverse transcribed at the same time. The RNA was extracted using the guanidinium 
thiocyanate-phenol-choloform extraction method, and the RNA concentration and A260/280 
purity was recorded using a NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Scientific).  A 
microgram of RNA was reverse transcribed into cDNA using an Omniscript RT Kit (Qiagen 
205113) and Random Primers (Promega C1181). The cDNA was then analyzed for genetic 
expression by real-time PCR using the Bio-Rad Thermal iCycler. Ten nanograms of cDNA were 
mixed with the IQ SYBR Green Supermix (Bio-Rad 170-8882) and underwent 40 cycles of 
amplification. The transcript levels were quantified relative to a standard curve of known 
concentration, and the results were normalized to the transcript levels of the housekeeping gene 
GAPDH. The genes, primer information, and annealing temperatures are listed below. All 
primers except Osteocalcin were designed using the Beacon Designer 7.0 program and then 
created by the company Operon. Osteocalcin was ordered through the Qiagen Global Gene 






Table 3 – Real-Time PCR Primers 








R CCT GCC TCC TTC CAC 
TAG C 
NM_013059 101 50 – 60oC 
 F ACA ACC TGA CTG ACC 
CTT CC 
   
Bone 
Sialoprotein II 
R AAT AAT CCT GAC CCT 
CGT AGC 
NM_012587 130 59.5oC 
 F TAC AAC ACT GCG TAT 
GAA ACC 
   
GAPDH R CAT ACT CAG CAC CAG 
CAT CAC C 
NM_017008 121 54.1oC 
 F AAG TTC AAC GGC ACA 
GTC AAG G 
   
Nucleostemin R TGC CCA GGT GAC ATC 
TCC 
NM_175580 155 55 – 60oC 
 F AAC AGA CAG AAG ACC 
AAC AGG 
   
Osteocalcin R Global Gene NM_013414 113 53.9oC 
 F Qiagen– QT01084573    
RUNX2 R AGA GGC AGA AGT CAG 
AGG 
XM_346016 121 60oC 
 F TCC CCA TCC ATC CAT 
TCC 
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Biochemical Assays 
After culturing the cells for 7 and 14 days the media and cells were used for our biochemical 
assays to determine the level of osteogenesis. 1mL of media was placed in a 1.5mL eppendorf tube and 
stored in the -20oC freezer. The cells were extracted with trypsin, counted in the particle counter, and 
stored in a 13 x 100mm borosilicate glass culture tube (VWR) suspended in 1mL of 0.05% of Triton-
X. After the 14-day harvest the cells were sonicated for 10 seconds at 40mA and the alkaline 
phosphatase specific activity was measured through a colormetric assay. The results were normalized 
to total protein with the use of a Micro BCA Protein Assay Kit (Pierce 23235). The media was used for 
a radioimmunoassay to determine the level of osteocalcin protein (BTI BT-440) and a sandwich 
E.L.I.S.A. to determine the level of osteoprotegerin protein (R&D DY459) secreted in the media. The 
total count was normalized to the cell number that was recorded at harvest. 
Statistics 
Statistical analysis of the results was made using a General Linear Model (GLM). Difference between 
the groups was determined by a multiple-comparison Tukey post hoc test. All graphs show the mean +/- 




THE NUMBER OF ASCs IN THE INGUINAL FAT PAD, BUT NOT THEIR 
OSTEOGENIC POTENTIAL, IS AGE DEPENDENT 
 
INTRODUCTION 
 Even though stem cells hold potential as the future of regenerative medicine, a great deal of 
work still needs to be done before these cells can reach their full clinical potential. Extensive research 
has shown that the ability to repair damage to our skeletal system decreases as we get older, yet we are 
still trying to discover the underlying mechanisms for this phenomenon. Figuring out why we lose this 
capability with age is important because any future stem cell therapy will ultimately depend upon the 
host’s system. Even if we prove that these ASCs can be used to repair damaged tissue, if the donor’s 
stem cell number is too small, if the stem cells don’t have the potential to repair tissue, or if the donor’s 
bone environment doesn’t send out the chemical signals require to initiate the healing process, then the 
therapy will ultimately be a failure. Therefore, it is imperative that we have a firm understanding of how 
age affects stem cells before we know how to implement any stem cell based therapy. Additionally, no 
studies have definitively shown where the ASCs residue within adipose tissue. The location of the ASCs 
will affect the chemical signals they are in contact with, and this can help shed light on their properties 
in relation to age. 
 The approach our group has taken with this study is to investigate how age affects ASCs from 
1M, 3M, and 9M male rats. These ages correlate to a pre-adolescent, adult, and older population. By 
using flow cytometry we hope to assess how age affects the number of stem and progenitor cells present 
in the inguinal fat pad, a source for these adult mesenchymal stem cells. We used 
immunohistochemistry to study where in the adipose tissue our CD271+/CD73+ ASC population 
residues. Furthermore, our in vitro studies allow us to monitor and access the osteogenic potential of 
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these ASCs in a 2D environment. This research will allow us to understand what challenges future 
researchers might face when dealing with an aged population. The results will allow clinicians to take 
precautionary steps to ensure that every patient, no matter their age, is provided with the right number of 
ASCs under the appropriate condition so that their regeneration can be successful.  
RESULTS 
 The result of this study shows that the percentage and number of ASCs and OPCs in male rat 
adipose tissue is age dependent, but that their osteogenic potential is not. The flow cytometry data 
shows that as age increases the number of ASCs decrease but the number of OPCs increases. Therefore, 
1M rats had significantly more ASCs than 9M rats, whereas the 9M rats had significantly more OPCs 
than the 1M rats. The histology indicates that our ASCs reside in the vasculature. We found co-
localization of CD73 and CD271 around both capillaries and veins within adipose tissue. Additionally, 
this study also shows that the osteogenic potential of these isolated cells in vitro is not age dependent. 
The ASCs in the osteogenic media produced a higher expression and level of osteogenic markers.  This 
increase was significant over the RNA expression and protein levels of cells in the control growth 
media.  While the increase was significant over the control media, no clear significance was seen 
between any of the age groups. Even though the different aged cells had the potential to undergo 
osteogenesis, there were differences in how the cells responded to the media. The older cells did not 







The ASCs are localized to the vasculature of adipose tissue 
When the adipose tissue was stained with CD73 and CD271 we saw co-localization of these 
markers on the cells near the vasculature (Fig. 1A,B). In Fig. 1A we can see the co-localization 
indicated by the yellow color around the capillary, and in Fig. 1B we can see co-localization around 
both a capillary and a vein. To demonstrate that the CD73/CD271 positive cells were around the 
vasculature we stained adjacent tissue slices with H&E as well as vWF, an endothelial specific marker. 
The tissue was mapped out so we could locate the same sites in multiple slides, therefore all the 
different images in Fig. 1A and 1B show the same vasculature but at a different depth in the adipose 
tissue. The H&E in Fig. 1A shows a capillary filled with red blood cells, and the H&E in Fig. 1B 
indicates a capillary below a vein. In both Fig. 1A and 1B the tissue is positive for vWF indicating that 
our images are of endothelial cells. Our controls are shown in Fig. 1C/D. Fig. 1C is a rabbit IgG control 
antibody for CD73 which was also raised in rabbits. Fig. 1D is a CD73 antibody that is specific for 
humans and was raised in a mouse. This is our control for CD271. Overall, the histology indicates that 


















Flow Cytometry  
The Number and Percent of ASCs and OPCs is Age Dependent 
The flow cytometry data of the primary adipose tissue showed an age related decrease in the 
percent of ASCs we were able to retrieve from the SVF (Fig. 2A). The percent of ASCs was higher in 
the 1M and 3M tissue than the 9M tissue. Additionally, we saw a decrease in the number of ASCs we 
were able to isolate from the SVF per gram of fat (Fig. 2B). The 1M tissue had significantly more ASCs 
per gram of fat than the 3M tissue. Additionally, there was an age related increase in the percent of 
OPCs we were able to isolate from the SVF (Fig. 2C, D). There was a significant increase in the 9M 
tissue over the 1M and 3M tissue. Although the 9M tissue showed an increase in the number of OPCs 
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isolated from the SVF per gram of fat, this increase was not significant.  The reason for this is that 
although the 9M animals had more overall adipose tissue in the inguinal fat pad, the number of cells 
isolated from the SVF per gram of fat was less than the 1M and 3M tissue. (Fig 2E).  When we looked 
at the individual ASC markers we noticed that the percent of cells in the SVF expressing CD271 
decreased with age (Fig. 2F). Additionally, OCN, a marker for OPCs increased with age although this 
was not significant between any of the groups (Fig. 2G). Overall, the percent of ASCs in the SVF 














Morphology and Cell Number 
 After the initial incision, we noticed that the young and old animals had different colored 
adipose tissue (Fig. 3B). The younger animals (6 weeks) displayed white adipose tissue (WAT) while 
the older animals had brown adipose tissue (BAT) as shown by the arrows. Additionally, the amount of 
adipose tissue in the inguinal fat pad increased in the older animals (data not shown). When we plated 
the cells in culture we noticed a decrease in the cell number for the 1M, 3M, and 9M cells when treated 
with the osteogenic media at 7 and 14 day (Fig. 3A). Additionally, when the cells were treated with 
GM, the 9M cells had a lower cell number than the 1M and 3M cells at 7 and 14 days, indicating a 
decrease in proliferation.  When the cells were examined at 14 days, there was a distinct difference in 
the morphology of the cells grown in GM and OM (Fig. 3C). The cells grown in GM were compact, 
grew on top of one another, and retained a fibroblast-like morphology consistent with previous stem cell 
characterizations. The cells grown in OM were larger and more spread out. Additionally, within each 
media condition there was no noticeable difference in the morphology of the 1M, 3M, and 9M cells. All 





















Biochemical Markers of Osteogenesis 
Protein Markers of Osteogenesis are Age Dependent 
 When the cells were treated with OM for 7 and 14 days there was an increase in the ALPase 
specific activity for the 1M and 9M cells (Fig. 4A).  There was no change in the ALPase specific 
activity for the 3M cells in either media or time point. There was also an increase in the OCN level for 
the cells treated with the OM at 7 and 14 days (Fig. 4B).  Furthermore, at both 7 and 14 days in the OM 
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the 3M and 9M cells had higher levels of OCN than the 1M cells.  The 1M, 3M, and 9M cells responded 
to the OM in a similar manner. (Fig. 4C). All the cells produced less OPG in the OM at 7 days. The 1M 
and 9M cells also produced less OPG in the OM at 14 days, but the level of OPG for the 3M cells did 
















Real-Time PCR for Markers of Osteogenesis 
Genetic Markers of Osteogenesis are Age Dependent 
The gene analysis showed that all the cells expressed the early markers of osteogenesis - 
RUNX2 and Alkaline Phosphatase - as well as the late markers - Bone Sialoprotein and Osteocalcin. 
There was very little fluctuation in the transcript levels of RUNX2 in both media conditions at 7 and 14 
days (Fig. 5A). The ALPase gene expression increased for all the cells at 7 days in the OM, but this was 
only significant for the 1M cells (Fig. 5B). The 1M cells also increased their ALPase expression over 
the 3M and 9M cells at 7 days in the OM. Additionally, at 14 days there was a decrease in the 
expression of ALP for the 1M and 3M cells treated with OM. The gene analysis for OCN showed a 
slight increase in the expression of OCN when all the cells were treated with OM (Fig. 5C). The 
expression was significant for the 9M cells at both 7 and 14 days, and this trend is similar to what was 
seen in the protein expression (Fig. 4B). The cells also showed an increase in the expression of BSP 
when treated with the OM for 7 and 14 days (Fig. 5D).  At 7 days this increase was significant for the 


























 The result of the adipose tissue flow cytometry indicates that the number and percent of ASCs 
decreases as the animal ages.  Although how we measured stem cells is unique, our work is in 
agreement with other studies.  Using a colony forming unit-fibroblast assay, Stolzing et al. found an age 
related decline in the number of bone marrow stem cells (BMSC).  Although BMSCs and ASCs are 
isolated from different anatomical sources, both of these cell types are mesoderm-derived stem cells.  
When we broke down the ASC markers we saw an age related decrease in the expression of CD271. 
This may indicate that CD271 selects for a more homogenous population of ASCs as some recent 
studies have indicated. Our results indicate that a reduction in the mesenchymal stem cell source may 
partially explain the decreased ability of our bodies to regenerate damaged tissue as we age.  It is 
important to note that both the number and percent of ASCs decreased with age. This is important 
because the older animals had more inguinal adipose tissue. However, even if we included the 
additional adipose tissue it is still likely that the younger animals would have had more total ASCs.  
 We also investigated how age affects the number of OPCs in adipose tissue. Our flow cytometry 
showed that the percent of OPCs increases as the animal ages. However, the results were not significant 
when looking at the number of OPCs because the younger animals had more cells per gram of adipose 
tissue.  It has been shown that as animals age their adipocytes size increases (Holm et al., 1975) and this 
may contribute to the lowered cells per gram of fat. It may also indicate that in older animals a higher 
percent of OPCs does not necessarily correlate with more total OPCs. When looking at the individual 
markers defining OPCs, the percent of E11 did not fluctuate greatly with age, but the percent of OCN 
did increase with age.  These results are in agreement with the flow cytometry results of Eghbali-
Fatoureci et al. who showed that the percentage of OCN+ cells in men increases with age.   This group 
was looking at whole blood samples so it is possible that our OCN+ cells were captured in the adipose 
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tissue vasculature.  This, along with recent studies showing that MSCs capable of osteogenesis reside in 
the perivascular niche, (da Silva Meirelles et al., 2008; Liu et al., 2009) indicates that our OPCs may 
evolve from cells embedded in the vasculature of adipose tissue. These cells may reside in the 
perivascular niche until needed and then respond to endocrine stimuli and migrate through the blood to 
the source of damaged tissue. If this is the case, the increase in OPCs with age may demonstrate an 
increase in bone turnover, or that ASCs lose their plasticity with age and begin to enter a more 
differentiated stage. 
            Our histology of the adipose tissue showed that the CD73 and CD271 positive ASCs are found 
in the vascular niche of adipose tissue. This is in agreement with other histological studies showing that 
ASCs are in the vasculature (Yamamoto et al., 2007; Zannettinno et al., 2008). This assessment fits 
because the vasculature is part of the stromal vasculature fraction that is extracted from the adipose 
tissue. It also suggests that the stem cells would have direct contact with chemical cues required to 
activate them for migration and differentiation. It would also imply that the ASCs could be used to 
repair damage to adipose tissue as well as other mesoderm-derived tissue throughout the body. Whether 
the ASCs stay within adipose tissue or are in constant fluctuation throughout the body still remains a 
mystery. Perhaps these mesenchymal stem cells that are isolated from a variety of tissues can move 
from one tissue source to another when needed. Addressing this question is important because if these 
stem cells are able to transport from one tissue to another then the adipose tissue itself may vary in the 
number of ASCs depending on the health of the individual. Finding a way to attract the stem cells to 
reside in adipose tissue and thus increase their concentration would be an interesting goal if this were 
the case.  
 We also discovered that the 9M cells had a lower cell number in culture, and this was significant 
at 7 and 14 days in the GM. Several other studies have shown that both ASC and BMSC lose their 
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adherence in culture and proliferate less (Zhu et al., 2009; Stolzing et al., 2008; Baxter et al., 2004). One 
possibility is that the older stem cells are less responsive to environmental cues with a reduction in cell 
signaling as Kasper et al. showed in their paper.  Additionally, we noticed that the tissue morphology 
between the younger and older animals was different, with the younger animals displaying WAT and 
the older animals having BAT.  While most noticeable BAT depots in humans disappear in adulthood, 
BAT remains in the rodent throughout its lifespan (Avram et al., 2007). Unlike WAT, BAT’s primary 
purpose is not to store excess energy, but rather it is used to release chemical energy in food as heat.  In 
older rodents BAT helps to regulate the body temperature, and although BAT may not be seen in adult 
humans, recent reports suggest that it still exists scattered within WAT. This is important because if 
rodent BAT has a lower percentage of ASC in the inguinal fat pad, different adipose sites in humans 
may also fluctuate in their percentage of ASC. If this is the case, it will be important to find the adipose 
depots in humans that yield the largest percentage of ASCs, especially for the older population.  
 When the ASCs were treated in culture with OM they increased their ALPase specific activity 
and OCN secretion. This demonstrates that regardless of age the ASCs have the potential to be pushed 
towards the osteoblast lineage since ALPase activity is an early marker and OCN a late marker of 
osteogenesis.  These results agree with several papers (Zuh et al., 2009; Shi et al., 2005) showing that 
young and old ASCs have the same osteogenic potential. Additionally, all three ages showed a 
significant increase in BSP mRNA in the OM. Since BSP has a high affinity for collagen and has been 
shown to help during the early hydroxyapatite nucleation (Harris et al., 2000), it can be considered a late 
marker of osteogenic differentiation. This would imply that the ASCs are not only forming the 
extracellular matrix, but they are also beginning to mineralize their matrix at 14 days.  We did not see an 
increase in RUNX2 expression when the cells were treated with OM, but this is not surprising. Previous 
research has shown that the mechanisms pushing a mesenchymal stem cell towards the osteoblast 
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lineage are tightly regulated, especially RUNX2 expression and protein activity (Bialek et al., 2004).  
RUNX2 is required to push the cell towards a pre-osteoblast stage but then must be inhibited by Snail1 
for the cell to continue towards matrix maturation.  Since our cells have already begun to increase their 
secretion of OCN at 7 days in OM, it is possible that the up regulation of RUNX2 precedes this time 
point.  Our results are similar to the work of de Frutos et al. who showed that osteoblast precursor cells 
pushed towards osteogenesis with a similar induction media saw the highest RUNX2 expression within 
2 days of induction.  By day 4 of induction the mRNA expression had already decreased to the baseline 
level. Future studies should address this property of RUNX2 regulation and collect RNA at an earlier 
time point.  With that said, the cells did show some differences in their response to the GM and OM. 
The level of OCN secretion was consistently higher in the older cells when treated with OM.  This 
correlates strongly with our flow cytometry results showing that the 9M cells express a higher 
percentage of OCN. Our real-time PCR results also support the protein studies with the older cells 
expressing more OCN mRNA in the OM at 7 and 14 days.  Additionally, the cells decreased their 
production of OPG in the OM. Although OPG can be used as a marker for osteogenesis, it has been 
shown (Kondo et al., 2008) that glucocorticoids like dexamethasone can decrease OPG production by 
either inhibiting c-Jun phosphorylation or down regulating β-catenin. Even though this was tested in 
bone-marrow derived osteoblastic/stromal cells, since our cells are a type of MSC and our OM media 
contains dexamethasone, it is possible that the same mechanisms are in play here.  
 The biochemical and mRNA assays we performed indicate that the older ASCs retain the same 
potential for osteogenesis as the younger ASCs.  This leads to the question of why the potential to 
regenerate damage tissue decreases as we age. As shown in figure 2, part of the reason could be a 
decrease in the number of stem cells as we age.  Additionally, extrinsic factors discussed by Conboy et 
al. could also come into play. In their studies that focus on parabiotic mice, they demonstrate that the 
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stem cell differentiation potential remains in tact, but the extrinsic cues required to activate the cell and 
initiate migration are altered as we age.  If this is the case, then it might be both a decrease in stem cell 
number and a change in the systemic environment that contributes to our loss in regenerative capacity as 














SEX AFFECTS THE NUMBER OF ASCs IN THE INGUINAL FAT PAD 
BUT NOT THEIR OSTEOGENIC DIFFERENTIATION POTENTIAL 
 
INTRODUCTION 
 As was shown in chapter 2, our knowledge of ASCs needs to go beyond the cell and also 
focus on the individual.  We demonstrated that the age of the individual affects both the number 
of stem cells and also their response in culture. Another factor that must be taken into 
consideration is the sex of the individual. This is important because men and women distribute 
adipose tissue differently. Women primarily accumulate adipose in their hips, while men 
predominantly deposit it in their abdomens. Furthermore, several researchers have demonstrated 
that ASCs from one adipose source does not necessarily have the same osteogenic potential as 
ASCs from another source. Taking this into consideration, it would not be surprising to discover 
that the best site for future male and female ASC harvest does not come from the same 
anatomical area.  
 The goal of this study was to examine how sex affects the number of ASCs and their 
osteogenic potential. Additionally, we harvested ASCs from two different aged male and female 
rats. Since adipose number and distribution changes with age (Zamboni et al., 1997), our study 
will allow us to examine any sex-based differences over time. We hope that this and future 
studies will allow researchers to develop an ideal stem cell harvest protocol not only based on 






 This study showed us that the number and percent of ASCs was not sex dependent at 3M 
or 9M. The number and percent of OPCs was not sex dependent at 3M, but it was at 9M. At 9M 
the number of OPCs was greater for the female rats than the male rats. When these cells were 
plated in culture both the males and females at 3M and 9M expressed markers of osteogenesis 
when inducted with the OM. This indicates that the stem cells from both sexes have a similar 
capacity to undergo osteogenesis when treated with the right conditions. We did notice some 
difference in how the cells responded to their media. Most significantly, the female cells 
maintained their levels of OPG while the males decreased the secretion of this protein in OM.  
Flow Cytometry 
The Number and Percent of OPCs, but not ASCs, is Sex Dependent 
 The flow cytometry of the cells extracted from 3M male and female adipose tissue 
showed no difference in the percent and number of ASCs (Fig. 6A, B).  The flow cytometry of 
the 9M male and female cells also showed no difference in the percent and number of ASCs. 
Additionally, the amount of ASCs in the 9M tissue was almost nonexistent, and much lower than 
the results for the 3M tissue. This result agrees with the flow cytometry in Figure 2.  The flow 
cytometry for OPCs showed no difference in the percent or number when comparing the 3M 
male and female cells (Fig. 6C, D). However, the number of OPCs in 9M tissue was significantly 
higher for the cells extracted from the female rats. The percent was also higher in the females 















To elucidate the reasons for any age or sex related difference in ASC or OPC percent, we 
looked at each cell population by their individual markers.  When we examined the 3M ASC 
population we saw that a higher percent of cells were CD271 positive than CD73 positive (Fig. 
7A). Additionally, although the cells from female tissue exhibited a higher percent of CD73 and 
CD271, there was no difference in the percent of ASCs between the two sexes at 3 months (Fig. 
6A). When we looked at the 9M ASC population we saw that a higher percent of cells were 
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CD73 positive than CD271 positive, the opposite of the 3M results (Fig. 7A).  The decrease in 
CD271 could be responsible for the lower ASC percent in the 9M cells. 
 We also looked at the 3M and 9M OPC population by OCN and E11 alone. Although the 
percent of E11 did not fluctuate much by age or sex, the percent of OCN did change (Fig. 7B). In 
the 3M cells the percent of OCN was higher in the male cells, whereas in the 9M cells the 
percent of OCN was higher in the female cells.  This could have caused the significant increase 














Biochemical Markers of Osteogenesis 
Cell Number and Protein Markers of Osteogenesis are Sex Dependent 
 The male and female cells responded to the conditioned media in a similar fashion. In the 
GM they had a higher cell number than when treated with the OM (Fig. 8A, B). However, we did 
observe some differences in how the male and female cells responded to their media.  The male 
cells had a higher cell number in the GM than the female cells. This was significant for the 3M 
cells but not for the 9M cells.  When the cells were treated with OM, the female cells appeared to 
have a higher cell number for both ages and time points, but this difference was not significant. 
 When the male and female cells were treated with the OM there was an increase in the 
ALPase specific activity (Fig. 8C, D).  In the 3M cells this increase was only observed at 7 days 
for the female cells, whereas in the 9M cells the increase was seen in both sexes at both time 
points. Additionally, the 3M female cells displayed a significantly higher level of ALPase 
specific activity over the males when treated with the OM for 7 days. When looking at the OCN 
levels, the male and female cells responded in a similar fashion and secreted more OCN when 
treated with the OM at 7 and 14 days (Fig. 8 E, F). This trend was seen for both the 3M and 9M 
cells. Finally, the male and female cells responded differently to the media in their secretion of 
OPG (Fig. 8G, H). The male cells decreased their OPG secretion when treated with the OM for 7 
days. Only the 3M female cells decreased their OPG secretion when treated with the OM for 7 
days. The 9M female cells did not show a significant change in the OPG levels when treated with 
either media. Furthermore, female cells secreted more OPG than the male cells. The 3M female 
cells produced significantly higher levels of OPG when treated for 7 and 14 days in both medias. 
The 9M female cells produced more OPG when treated with the OM for 7 and 14 days.  
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Therefore, the female cells generally had a higher level of OPG when treated with both the GM 


















Real-Time PCR Markers of Osteogenesis 
Genetic Markers of Osteogenesis are Sex Dependent 
 Similar to the results in Fig. 5, we saw very little fluctuation in the RUNX2 expression 
for the 3M male and female cells (Fig. 9A). Both sexes showed an increase in ALPase 
expression when treated with the osteogenic media (Fig. 9B). At 14 days in the OM the male 
cells showed an increase while the females showed a significant increase. At this time point the 
expression of ALPase was significantly higher for the females than the males.  This agreed with 
our protein studies from Fig. 8. For the OCN expression there was not a significant fluctuation at 
any time point (Fig. 9C). However, at 14 days in the OM there appeared to be an increase over 
the GM for both the males and females. Finally, there was a significant increase in the BSP 
expression for the 3M male and females when treated with OM for 14 days (Fig. 9D). 












 The second aim focused on the role sex plays in ASC number and osteogenic 
differentiation potential. We chose to focus our study on 3M and 9M male and female rats.  We 
chose these ages because at 3M the rats are just starting their sexual maturity, and at 9M they 
have stopped their skeletal development. Due to these circumstances, we believe that the adipose 
microenvironment and hormonal balance would be most different at these ages.  We saw from 
our flow cytometry that the number and percent of ASCs in the inguinal fat pad is the same for 
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3M and 9M male and female rats.  We also noticed that the percent and number of ASCs for the 
9M rats was almost nonexistent, and this further validates our finding in the first study.  When 
we broke the phenotypes into their individual markers, we saw a large reduction in the 
percentage of CD271 positive cells in the 9M rats.  Recent reports have provided evidence that 
CD271 is a specific marker of ASCs. Bone marrow and adipose tissue isolates selected for 
CD271 yielded a subset of cells with a higher proliferative and osteogenic differentiation 
capacity than the CD271 negative population (Yamamoto et al., 2007; Quirici et al., 2009). This 
would indicate that CD271 selects for a more homogenous ASC population, and that the 
reduction of CD271 in our 9M cells indicates a lower percentage of ASCs in the rat inguinal 
adipose tissue.  When we looked at the number and percent of OPCs we saw no differences at 
3M, but at 9M the number of OPCs is significantly higher in the female rats.  Looking at figure 7 
we can see that the percent of E11 is the same at 9M, however, the females express more OCN.  
Several studies have indicated that OCN levels are inversely related to bone mineral density 
(BMD). Also, it is known that OCN increases in women with age, and that older women have an 
increase in bone turnover and a lower BMD (Lumachi et al., 2009). Additionally, the 9M 
females had a higher cell yield per gram of adipose tissue (results not shown). The combination 
of these two can explain the increase in OPCs in the 9M females over the males.  
 When the cells were plated in culture we saw that both the 3M and 9M male and female 
rats had a similar tendency to express markers of osteogenesis when given the OM.  Both sexes 
increased their cell number in the GM over the OM, and this occurred at 3M and 9M.  When 
looking at the ALPase activity and the OCN secretion, both sexes increased these osteoblast 
markers in the OM. For the ALPase activity, the 3M female rats had significantly higher 
numbers at 7 days in the OM, but this increase was not seen at 9M. For the OCN secretion, both 
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sexes and ages showed significantly higher numbers in the OM at 7 and 14 days, but there was 
no difference between the sexes.  These results for the female ASCs agree with the work of Zuh 
et al. showing that female human ASCs retain their osteogenic potential with age. Although the 
3M and 9M female cells were not run together, both cells responded to the OM and increased 
their ALPase activity and OCN secretion.  The real-time PCR further supports the protein studies 
by showing an increase in ALPase, OCN, and BSP mRNA at 14 days when the 3M male and 
female cells were treated with OM, although the results are not significant for OCN.  Our results 
for the sex study tend to disagree with the results of Aksu et al. showing that adipose tissue from 
males has a higher osteogenic potential than females.  Our two studies have several differences 
though, most importantly is their use of abdominal subcutaneous tissue from humans, while we 
used tissue from the inguinal fat pad of rats.  Their results indicate that male adipose tissue has a 
higher osteogenic potential and that adipose from the superficial layer has a higher 
differentiation potential than adipose from the deep layer. They speculated that this might be due 
to the increased vasculature of the superficial adipose tissue, and this would be in agreement with 
the results of Peptan et al. Although it is hard to compare our two studies, it is important to 
remember that men and women distribute adipose tissue to different regions. Therefore, one 
source of tissue might have a higher osteogenic potential in men, while another source would 
have a higher osteogenic potential in women. It will be important to study the ASC potential 
from different anatomical sources and sexes since any differences will help optimize future ASC 
therapies.  Finally, we saw a large difference in the secretion of OPG between the sexes in both 
the 3M and 9M cells. While the male ASCs decreased their production of OPG in the OM, the 
female cells were able to retain their levels in both medias. It has been demonstrated that 
estrogen can up regulate the production of OPG, an inhibitor of osteoclastogenesis (Szulc et al., 
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2008). Additionally, studies have shown that rat and human female adipose tissue, including 
cells in the stromal vascular fraction, express the estrogen receptor (ER) (Mizutani et al., 1994). 
We also known that the phenol red used in our media is able to mimic the effects of estrogen 
(Bindal et al., 1988).  Given this information, we believe that the media may have played a role 
in stimulating the ERs of female ASCs to maintain their production of OPG in the OM. This is 
important because OPG plays a key role in preventing osteoclast maturation by binding the 
RANKL, and so ASCs expressing this protein might be able to better promote bone formation by 
inhibiting bone loss in vivo. 
 Our study is important for clinicians using ASCs because we demonstrate that the 
osteogenic potential of male and female ASCs is similar, although differences do exist to how 
they respond in culture.  With that said, we realize that there are limitations to this work. One of 
the major obstacles is the source of adipose tissue, since all the adipose tissue was taken from the 
same site, the inguinal fat pad. Future studies that address sex-based ASC differences should 
compare these stem cells from different anatomical sources in men and women. This will allow 
researchers to examine the possibility that the ideal source of ASCs from one sex is not the same 
as in the other sex. It will also ensure that the optimal isolation procedures are in place so that we 
can yield the maximum amount of ASCs with the best osteogenic potential from each patient.  
CONCLUSION AND CLINICAL IMPLICATIONS  
 This work helps shed light on the ASC location, as well as the number and osteogenic 
differentiation potential in regards to age and sex. In aim 1 we discovered that the cells positive 
for CD73 and CD271 were found in and around the vasculature. Most likely these cells reside in 
the vasculature niche of adipose tissue until a chemical signal triggers them for migration. The 
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vasculature would afford them the easiest opportunity to migrate to a site within adipose tissue 
and around the body. Perhaps these ASCs can both originate from other sources like the bone 
marrow, and also contribute to the regeneration of mesoderm derived organs around the body.  
 We also discovered that the number of ASCs decreases with increasing age. This could 
help explain why our ability to regenerate tissue decreases as we age. As we age our partially 
exhausted source of stem cells impairs our ability to fix damaged tissue in a timely and efficient 
manner. Clinicians may need to isolate more adipose tissue from older patients, or expand their 
number in culture, to yield the appropriate number of stem cells. Additionally, in aim 1.3 we 
discovered that once placed in culture and feed with an osteogenic media, age did not affect the 
potential of the ASCs to differentiate down the osteogenic lineage. This would imply that the 
intrinsic ability of the stem cell is maintained with age and indicate that extrinsic factors could 
play a role in stem cell potential with age. As I pointed out earlier, several authors have shown 
that extrinsic chemical cues needed to trigger the stem cells for migration and differentiation are 
either inhibited or not present with increasing age. It could be both a decrease in stem cell 
number as well as a reduction in the extrinsic factors needed for stem cell migration that cause 
the decrease in tissue regeneration with age.  
 In aim 2 we investigated how sex affects the ASC number and osteogenic potential. We 
saw that male and female ASCs at 3 and 9 months have a similar number of stem cells in the 
adipose tissue. Additionally, when grown in culture the males and females maintain a similar 
osteogenic differentiation potential. The main difference was that the 3M and 9M female ASCs 
had higher levels of osteoprotegerin in both the GM and OM. This may indicate that the female 
ASCs could help prevent bone loss in vivo by their increased production of OPG. Future studies 
should address this phenomenon by studying the difference in the number of steroid receptors 
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between male and female ASCs. Perhaps the female ASCs have a higher number of estrogen 
receptors which may have helped them maintain their levels of OPG in the presence of 
dexamethasone, a known inhibitor of OPG. Furthermore, because male and female humans have 
a different distribution pattern of adipose tissue, it will be important to see how location affects 
ASC number. Previous studies indicate that location does affect the osteogenic potential of the 
ASCs, and so the optimal site for ASC retrieval between men and women may be different.  
 This work provides clinicians with additional insight into the properties of ASCs. It is 
important because these stem cells will be targeted to people of different ages, sexes, and 
medical conditions. Understanding ASC number and potential in regard to these factors will help 











Aksu AE, JP Rubin, JR Dudas and KG Marra. (2008). Role of gender and anatomical region on 
induction of osteogenic differentiation of human adipose-derived stem cells. Ann Plast Surg 
60:306-22. 
 
Astori G, F Vignati, S Bardelli, M Tubio, M Gola, V Albertini, F Bambi, G Scali, D Castelli, V 
Rasini, G Soldati and T Moccetti. (2007). "In vitro" and multicolor phenotypic characterization 
of cell subpopulations identified in fresh human adipose tissue stromal vascular fraction and in 
the derived mesenchymal stem cells. J Transl Med 5:55. 
 
Avram AS, MM Avram and WD James. (2005). Subcutaneous fat in normal and diseased states: 
2. Anatomy and physiology of white and brown adipose tissue. J Am Acad Dermatol 53:671-83. 
 
Avram MM, AS Avram and WD James. (2005). Subcutaneous fat in normal and diseased states: 
1. Introduction. J Am Acad Dermatol 53:663-70. 
 
Avram MM, AS Avram and WD James. (2007). Subcutaneous fat in normal and diseased states 
3. Adipogenesis: from stem cell to fat cell. J Am Acad Dermatol 56:472-92. 
 
Barry F, R Boynton, M Murphy, S Haynesworth and J Zaia. (2001). The SH-3 and SH-4 
antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem 
Biophys Res Commun 289:519-24. 
 
Baxter MA, RF Wynn, SN Jowitt, JE Wraith, LJ Fairbairn and I Bellantuono. (2004). Study of 
telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. 
Stem Cells 22:675-82. 
 
Bialek P, B Kern, X Yang, M Schrock, D Sosic, N Hong, H Wu, K Yu, DM Ornitz, EN Olson, 
MJ Justice and G Karsenty. (2004). A twist code determines the onset of osteoblast 
differentiation. Dev Cell 6:423-35. 
 
Bindal RD and JA Katzenellenbogen. (1988). Bis(4-hydroxyphenyl)[2-
(phenoxysulfonyl)phenyl]methane: isolation and structure elucidation of a novel estrogen from 
commercial preparations of phenol red (phenolsulfonphthalein). J Med Chem 31:1978-83. 
 
Carlson ME and IM Conboy. (2007). Loss of stem cell regenerative capacity within aged niches. 
Aging Cell 6:371-82. 
Conboy IM, MJ Conboy, AJ Wagers, ER Girma, IL Weissman and TA Rando. (2005). 
Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 
433:760-4. 
 
D'Ippolito G, PC Schiller, C Ricordi, BA Roos and GA Howard. (1999). Age-related osteogenic 




da Silva Meirelles L, AI Caplan and NB Nardi. (2008). In search of the in vivo identity of 
mesenchymal stem cells. Stem Cells 26:2287-99. 
 
de Frutos CA, R Dacquin, S Vega, P Jurdic, I Machuca-Gayet and MA Nieto. (2009). Snail1 
controls bone mass by regulating Runx2 and VDR expression during osteoblast differentiation. 
EMBO J 28:686-96. 
 
Eghbali-Fatourechi GZ, UI Modder, N Charatcharoenwitthaya, A Sanyal, AH Undale, JA 
Clowes, JE Tarara and S Khosla. (2007). Characterization of circulating osteoblast lineage cells 
in humans. Bone 40:1370-7. 
 
Fisher M, S Hyzy, RE Guldberg, Z Schwartz and BD Boyan. (2009). Regeneration of bone 
marrow after tibial ablation in immunocompromised rats is age dependent. Bone. 
 
Freedman DS, SJ Jacobsen, JJ Barboriak, KA Sobocinski, AJ Anderson, AH Kissebah, EA Sasse 
and HW Gruchow. (1990). Body fat distribution and male/female differences in lipids and 
lipoproteins. Circulation 81:1498-506. 
 
Guyton AC and JE Hall. (2006). Textbook of medical physiology. Elsevier Saunders, 
Philadelphia. 
 
Harris NL, KR Rattray, CE Tye, TM Underhill, MJ Somerman, JA D'Errico, AF Chambers, GK 
Hunter and HA Goldberg. (2000). Functional analysis of bone sialoprotein: identification of the 
hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-
directed mutagenesis. Bone 27:795-802. 
 
Holm G, B Jacobsson, P Bjorntorp and U Smith. (1975). Effects of age and cell size on rat 
adipose tissue metabolism. J Lipid Res 16:461-4. 
 
Kasper G, L Mao, S Geissler, A Draycheva, J Trippens, J Kuhnisch, M Tschirschmann, K 
Kaspar, C Perka, GN Duda and J Klose. (2009). Insights into mesenchymal stem cell aging: 
involvement of antioxidant defense and actin cytoskeleton. Stem Cells 27:1288-97. 
 
Kern S, H Eichler, J Stoeve, H Kluter and K Bieback. (2006). Comparative analysis of 
mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 
24:1294-301. 
 
Kondo T, R Kitazawa, A Yamaguchi and S Kitazawa. (2008). Dexamethasone promotes 
osteoclastogenesis by inhibiting osteoprotegerin through multiple levels. J Cell Biochem 
103:335-45. 
 
Liu ZJ, Y Zhuge and OC Velazquez. (2009). Trafficking and differentiation of mesenchymal 
stem cells. J Cell Biochem 106:984-91. 
 
  49 
Lufkin EG. (1992). Therapeutic alternatives for postmenopausal osteoporosis. Compr Ther 
18:14-7. 
 
Lumachi F, M Ermani, V Camozzi, V Tombolan and G Luisetto. (2009). Changes of bone 
formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women 
with osteoporosis. Ann N Y Acad Sci 1173 Suppl 1: E60-3. 
 
Mitchell JB, K McIntosh, S Zvonic, S Garrett, ZE Floyd, A Kloster, Y Di Halvorsen, RW 
Storms, B Goh, G Kilroy, X Wu and JM Gimble. (2006). Immunophenotype of human adipose-
derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem 
Cells 24:376-85. 
 
Mizutani T, Y Nishikawa, H Adachi, T Enomoto, H Ikegami, H Kurachi, T Nomura and A 
Miyake. (1994). Identification of estrogen receptor in human adipose tissue and adipocytes. J 
Clin Endocrinol Metab 78:950-4. 
 
Niemeyer P, M Kornacker, A Mehlhorn, A Seckinger, J Vohrer, H Schmal, P Kasten, V 
Eckstein, NP Sudkamp and U Krause. (2007). Comparison of immunological properties of bone 
marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic 
differentiation in vitro. Tissue Eng 13:111-21. 
 
Peptan IA, L Hong and JJ Mao. (2006). Comparison of osteogenic potentials of visceral and 
subcutaneous adipose-derived cells of rabbits. Plast Reconstr Surg 117:1462-70. 
 
Quinn R. (2005). Comparing rat's to human's age: how old is my rat in people years? Nutrition 
21:775-7. 
 
Quirici N, C Scavullo, L de Girolamo, S Lopa, E Arrigoni, G Lambertenghi Deliliers and AT 
Brini. (2009). Anti-L-NGFR and -CD34 Monoclonal Antibodies identify multipotent 
mesenchymal stem cells in human adipose tissue. Stem Cells Dev. 
 
Quirici N, D Soligo, P Bossolasco, F Servida, C Lumini and GL Deliliers. (2002). Isolation of 
bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp 
Hematol 30:783-91. 
 
Riggs BL, S Khosla and LJ Melton, 3rd. (1998). A unitary model for involutional osteoporosis: 
estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and 
contributes to bone loss in aging men. J Bone Miner Res 13:763-73. 
 
Schaffler A and C Buchler. (2007). Concise review: adipose tissue-derived stromal cells--basic 
and clinical implications for novel cell-based therapies. Stem Cells 25:818-27. 
 
Shi YY, RP Nacamuli, A Salim and MT Longaker. (2005). The osteogenic potential of adipose-
derived mesenchymal cells is maintained with aging. Plast Reconstr Surg 116:1686-96. 
 
  50 
Simpson ER, GE Ackerman, ME Smith and CR Mendelson. (1981). Estrogen formation in 
stromal cells of adipose tissue of women: induction by glucocorticosteroids. Proc Natl Acad Sci 
U S A 78:5690-4. 
 
Stolzing A, E Jones, D McGonagle and A Scutt. (2008). Age-related changes in human bone 
marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 
129:163-73. 
 
Szulc P, LC Hofbauer, AE Heufelder, S Roth and PD Delmas. (2001). Osteoprotegerin serum 
levels in men: correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 
86:3162-5. 
 
Wagner W, S Bork, P Horn, D Krunic, T Walenda, A Diehlmann, V Benes, J Blake, FX Huber, 
V Eckstein, P Boukamp and AD Ho. (2009). Aging and replicative senescence have related 
effects on human stem and progenitor cells. PLoS One 4:e5846. 
 
Yamamoto N, H Akamatsu, S Hasegawa, T Yamada, S Nakata, M Ohkuma, E Miyachi, T 
Marunouchi and K Matsunaga. (2007). Isolation of multipotent stem cells from mouse adipose 
tissue. J Dermatol Sci 48:43-52. 
 
Zannettinno ACW, S Paton, A Arthur, F Khor, S Itescu, JM Gimble and S Gronthos. (2008). 
Multipotential Human Adipose-Derived Stromal Stem Cells Exhibit a Perivascular Phenotype in 
Vitro and In Vivo. J Cell Physiol 214: 413-21.  
 
Zamboni M, F Armellini, T Harris, E Turcato, R Micciolo, IA Bergamo-Andreis and O Bosello. 
(1997). Effects of age on body fat distribution and cardiovascular risk factors in women. Am J 
Clin Nutr 66:111-5. 
 
Zhang K, C Barragan-Adjemian, L Ye, S Kotha, M Dallas, Y Lu, S Zhao, M Harris, SE Harris, 
JQ Feng and LF Bonewald. (2006). E11/gp38 selective expression in osteocytes: regulation by 
mechanical strain and role in dendrite elongation. Mol Cell Biol 26:4539-52. 
 
Zhu M, E Kohan, J Bradley, M Hedrick, P Benhaim and P Zuk. (2009). The effect of age on 
osteogenic, adipogenic and proliferative potential of female adipose-derived stem cells. J Tissue 
Eng Regen Med 3:290-301. 
 
Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, HP Lorenz and MH 
Hedrick. (2001). Multilineage cells from human adipose tissue: implications for cell-based 
therapies. Tissue Eng 7:211-28. 
 
 
